Finally, Effective Inhibitors of Mutant KRAS
- PMID: 34161711
- DOI: 10.1056/NEJMe2107884
Finally, Effective Inhibitors of Mutant KRAS
Comment on
-
Sotorasib for Lung Cancers with KRAS p.G12C Mutation.N Engl J Med. 2021 Jun 24;384(25):2371-2381. doi: 10.1056/NEJMoa2103695. Epub 2021 Jun 4. N Engl J Med. 2021. PMID: 34096690 Free PMC article. Clinical Trial.
-
Acquired Resistance to KRASG12C Inhibition in Cancer.N Engl J Med. 2021 Jun 24;384(25):2382-2393. doi: 10.1056/NEJMoa2105281. N Engl J Med. 2021. PMID: 34161704 Free PMC article.
Similar articles
-
Dimerization Is Critical for the Functions of Wild-type and Mutant KRAS.Cancer Discov. 2018 Mar;8(3):262. doi: 10.1158/2159-8290.CD-RW2018-013. Epub 2018 Jan 26. Cancer Discov. 2018. PMID: 29374019
-
Pharmacological Induction of RAS-GTP Confers RAF Inhibitor Sensitivity in KRAS Mutant Tumors.Cancer Cell. 2018 Oct 8;34(4):611-625.e7. doi: 10.1016/j.ccell.2018.09.002. Cancer Cell. 2018. PMID: 30300582
-
A role for the unfolded protein response stress sensor ERN1 in regulating the response to MEK inhibitors in KRAS mutant colon cancers.Genome Med. 2018 Nov 27;10(1):90. doi: 10.1186/s13073-018-0600-z. Genome Med. 2018. PMID: 30482246 Free PMC article.
-
Targeting KRAS mutant cancers by preventing signaling transduction in the MAPK pathway.Eur J Med Chem. 2021 Feb 5;211:113006. doi: 10.1016/j.ejmech.2020.113006. Epub 2020 Nov 17. Eur J Med Chem. 2021. PMID: 33228976 Review.
-
Targeting the MAPK Pathway in KRAS-Driven Tumors.Cancer Cell. 2020 Apr 13;37(4):543-550. doi: 10.1016/j.ccell.2020.03.013. Cancer Cell. 2020. PMID: 32289276 Review.
Cited by
-
KRAS Mutation Subtypes and Their Association with Other Driver Mutations in Oncogenic Pathways.Cells. 2024 Jul 19;13(14):1221. doi: 10.3390/cells13141221. Cells. 2024. PMID: 39056802 Free PMC article. Review.
-
Identification of a recurrent mosaic KRAS variant in brain tissue from an individual with nevus sebaceous syndrome.Cold Spring Harb Mol Case Stud. 2021 Dec 9;7(6):a006133. doi: 10.1101/mcs.a006133. Print 2021 Dec. Cold Spring Harb Mol Case Stud. 2021. PMID: 34649968 Free PMC article.
-
Examining Farnesyltransferase Interaction With Cell-Permeable CaaX Peptides and the Role of the CaaX Motif in Biological Activity.J Pept Sci. 2025 Apr;31(4):e70009. doi: 10.1002/psc.70009. J Pept Sci. 2025. PMID: 40064612 Free PMC article.
-
SOS1 inhibitor BI-3406 shows in vivo antitumor activity akin to genetic ablation and synergizes with a KRASG12D inhibitor in KRAS LUAD.Proc Natl Acad Sci U S A. 2025 Mar 18;122(11):e2422943122. doi: 10.1073/pnas.2422943122. Epub 2025 Mar 12. Proc Natl Acad Sci U S A. 2025. PMID: 40073053
-
Targeting KRAS mutant lung cancer: light at the end of the tunnel.Mol Oncol. 2022 Mar;16(5):1057-1071. doi: 10.1002/1878-0261.13168. Epub 2022 Jan 18. Mol Oncol. 2022. PMID: 34951114 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous